Atellica Solution Portfolio: Engineering predictability in a highly unpredictable lab environment

In this interview, News Med talks to Lisa Cratty about the unpredictable lab environment and
engineering predictability.

Praxis’ epilepsy drug reduces seizures by 46% in pediatric patients in Phase 2 study

Praxis Precision Medicines released another batch of topline data from its epilepsy program on Tuesday, this time from the Phase 2 EMBOLD study investigating relutrigine

September 4, 2024

What the U.S. can learn from Portugal’s health system

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Let’s get to the news.

December 10, 2024

Study identifies potential gain of function mutation in retinoblastoma

A new research paper was published in Volume 16 of Genes & Cancer on January 20, 2025, entitled, “Analysis of pathogenic variants in retinoblastoma reveals

January 29, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.